Myeloid cell derived HOCl is a paracrine effector that trans-inhibits IKK/NF-kB in melanoma cells and limits early tumor progression

Tracy W. Liu, Seth T. Gammon, Ping Yang, David Fuentes, David Piwnica Worms

Research output: Contribution to journal › Article › peer-review

16 Scopus citations

Fingerprint

Dive into the research topics of 'Myeloid cell derived HOCl is a paracrine effector that trans-inhibits IKK/NF-kB in melanoma cells and limits early tumor progression'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemistry